A Differential Role for Macropinocytosis in Mediating Entry of the Two Forms of Vaccinia Virus into Dendritic Cells
Vaccinia virus (VACV) is being developed as a recombinant viral vaccine vector for several key pathogens. Dendritic cells (DCs) are specialised antigen presenting cells that are crucial for the initiation of primary immune responses; however, the mechanisms of uptake of VACV by these cells are unclear. Therefore we examined the binding and entry of both the intracellular mature virus (MV) and extracellular enveloped virus (EV) forms of VACV into vesicular compartments of monocyte-derived DCs. Using a panel of inhibitors, flow cytometry and confocal microscopy we have shown that neither MV nor EV binds to the highly expressed C-type lectin receptors on DCs that are responsible for capturing many other viruses. We also found that both forms of VACV enter DCs via a clathrin-, caveolin-, flotillin- and dynamin-independent pathway that is dependent on actin, intracellular calcium and host-cell cholesterol. Both MV and EV entry were inhibited by the macropinocytosis inhibitors rottlerin and dimethyl amiloride and depended on phosphotidylinositol-3-kinase (PI(3)K), and both colocalised with dextran but not transferrin. VACV was not delivered to the classical endolysosomal pathway, failing to colocalise with EEA1 or Lamp2. Finally, expression of early viral genes was not affected by bafilomycin A, indicating that the virus does not depend on low pH to deliver cores to the cytoplasm. From these collective results we conclude that VACV enters DCs via macropinocytosis. However, MV was consistently less sensitive to inhibition and is likely to utilise at least one other entry pathway. Definition and future manipulation of these pathways may assist in enhancing the activity of recombinant vaccinia vectors through effects on antigen presentation.
Vyšlo v časopise:
A Differential Role for Macropinocytosis in Mediating Entry of the Two Forms of Vaccinia Virus into Dendritic Cells. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000866
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000866
Souhrn
Vaccinia virus (VACV) is being developed as a recombinant viral vaccine vector for several key pathogens. Dendritic cells (DCs) are specialised antigen presenting cells that are crucial for the initiation of primary immune responses; however, the mechanisms of uptake of VACV by these cells are unclear. Therefore we examined the binding and entry of both the intracellular mature virus (MV) and extracellular enveloped virus (EV) forms of VACV into vesicular compartments of monocyte-derived DCs. Using a panel of inhibitors, flow cytometry and confocal microscopy we have shown that neither MV nor EV binds to the highly expressed C-type lectin receptors on DCs that are responsible for capturing many other viruses. We also found that both forms of VACV enter DCs via a clathrin-, caveolin-, flotillin- and dynamin-independent pathway that is dependent on actin, intracellular calcium and host-cell cholesterol. Both MV and EV entry were inhibited by the macropinocytosis inhibitors rottlerin and dimethyl amiloride and depended on phosphotidylinositol-3-kinase (PI(3)K), and both colocalised with dextran but not transferrin. VACV was not delivered to the classical endolysosomal pathway, failing to colocalise with EEA1 or Lamp2. Finally, expression of early viral genes was not affected by bafilomycin A, indicating that the virus does not depend on low pH to deliver cores to the cytoplasm. From these collective results we conclude that VACV enters DCs via macropinocytosis. However, MV was consistently less sensitive to inhibition and is likely to utilise at least one other entry pathway. Definition and future manipulation of these pathways may assist in enhancing the activity of recombinant vaccinia vectors through effects on antigen presentation.
Zdroje
1. DubskyP
UenoH
PiquerasB
ConnollyJ
BanchereauJ
2005 Human dendritic cell subsets for vaccination. J Clin Immunol 25 551 572
2. SteinmanRM
HemmiH
2006 Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311 17 58
3. van VlietSJ
Garcia-VallejoJJ
van KooykY
2008 Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses. Immunol Cell Biol 86 580 587
4. DohertyGJ
McMahonHT
2009 Mechanisms of Endocytosis. Annu Rev Biochem 78 857 902
5. MayorS
PaganoRE
2007 Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8 603 612
6. ConditRC
MoussatcheN
TraktmanP
2006 In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66 31 124
7. RobertsKL
SmithGL
2008 Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16 472 479
8. SmithGL
VanderplasschenA
LawM
2002 The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83 2915 2931
9. VanderplasschenA
SmithGL
1997 A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol 71 4032 4041
10. ChungCS
HsiaoJC
ChangYS
ChangW
1998 A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol 72 1577 1585
11. VazquezMI
EstebanM
1999 Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus. J Virol 73 9098 9109
12. LinCL
ChungCS
HeineHG
ChangW
2000 Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J Virol 74 3353 3365
13. ChiuWL
LinCL
YangMH
TzouDL
ChangW
2007 Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin. J Virol 81 2149 2157
14. CarterGC
LawM
HollinsheadM
SmithGL
2005 Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol 86 1279 1290
15. FooCH
LouH
WhitbeckJC
Ponce-de-LeonM
AtanasiuD
2009 Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans. Virology 385 368 382
16. LawM
CarterGC
RobertsKL
HollinsheadM
SmithGL
2006 Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A 103 5989 5994
17. ChahroudiA
ChavanR
KozyrN
WallerEK
SilvestriG
2005 Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J Virol 79 10397 10407
18. WhitbeckJC
FooCH
Ponce de LeonM
EisenbergRJ
CohenGH
2009 Vaccinia virus exhibits cell-type-dependent entry characteristics. Virology 385 383 391
19. MossB
2006 Poxvirus entry and membrane fusion. Virology 344 48 54
20. RobertsKL
BreimanA
CarterGC
EwlesHA
HollinsheadM
2009 Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol 90 1582 1591
21. TownsleyAC
WeisbergAS
WagenaarTR
MossB
2006 Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal Pathway. J Virol 80 8899 8908
22. TownsleyAC
MossB
2007 Two distinct low-pH steps promote entry of vaccinia virus. J Virol 81 8613 8620
23. MercerJ
HeleniusA
2008 Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320 531 535
24. IchihashiY
1996 Extracellular enveloped vaccinia virus escapes neutralization. Virology 217 478 485
25. VanderplasschenA
HollinsheadM
SmithGL
1998 Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 79 (Pt 4) 877 887
26. DrillienR
SpehnerD
BohbotA
HanauD
2000 Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 268 471 481
27. LiaoJF
PerkinsJP
1993 Differential effects of antimycin A on endocytosis and exocytosis of transferrin also are observed for internalization and externalization of beta-adrenergic receptors. Mol Pharmacol 44 364 370
28. PelkmansL
2005 Viruses as probes for systems analysis of cellular signalling, cytoskeleton reorganization and endocytosis. Curr Opin Microbiol 8 331 337
29. LehmannMJ
ShererNM
MarksCB
PypaertM
MothesW
2005 Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J Cell Biol 170 317 325
30. LamazeC
FujimotoLM
YinHL
SchmidSL
1997 The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 272 20332 20335
31. TurvilleSG
ArthosJ
DonaldKM
LynchG
NaifH
2001 HIV gp120 receptors on human dendritic cells. Blood 98 2482 2488
32. HenleyJR
KruegerEW
OswaldBJ
McNivenMA
1998 Dynamin-mediated internalization of caveolae. J Cell Biol 141 85 99
33. HinshawJE
SchmidSL
1995 Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374 190 192
34. GrimmerS
van DeursB
SandvigK
2002 Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 115 2953 2962
35. ChungCS
HuangCY
ChangW
2005 Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J Virol 79 1623 1634
36. GlebovOO
BrightNA
NicholsBJ
2006 Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 8 46 54
37. NorburyCC
ChambersBJ
PrescottAR
LjunggrenHG
WattsC
1997 Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 27 280 288
38. SallustoF
CellaM
DanieliC
LanzavecchiaA
1995 Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 389 400
39. ZenniMK
GiardinaPC
HarveyHA
ShaoJ
KettererMR
2000 Macropinocytosis as a mechanism of entry into primary human urethral epithelial cells by Neisseria gonorrhoeae. Infect Immun 68 1696 1699
40. Alpuche-ArandaCM
RacoosinEL
SwansonJA
MillerSI
1994 Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes. J Exp Med 179 601 608
41. AmstutzB
GastaldelliM
KalinS
ImelliN
BouckeK
2008 Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 27 956 969
42. LiberaliP
KakkonenE
TuracchioG
ValenteC
SpaarA
2008 The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J 27 970 981
43. MercerJ
HeleniusA
2009 Virus entry by macropinocytosis. Nat Cell Biol 11 510 520
44. WangJH
WellsC
WuL
2008 Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells. Virology 381 143 154
45. HuangCY
LuTY
BairCH
ChangYS
JwoJK
2008 A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J Virol 82 7988 7999
46. FalconeS
CocucciE
PodiniP
KirchhausenT
ClementiE
2006 Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci 119 4758 4769
47. PelkmansL
HeleniusA
2003 Insider information: what viruses tell us about endocytosis. Curr Opin Cell Biol 15 414 422
48. SarkarK
KruhlakMJ
ErlandsenSL
ShawS
2005 Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology 116 513 524
49. JonesAT
2007 Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med 11 670 684
50. NorburyCC
MalideD
GibbsJS
BenninkJR
YewdellJW
2002 Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3 265 271
51. BastaS
ChenW
BenninkJR
YewdellJW
2002 Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells. J Immunol 168 5403 5408
52. OrlandiPA
FishmanPH
1998 Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 141 905 915
53. VidalainPO
AzocarO
Servet-DelpratC
Rabourdin-CombeC
GerlierD
2000 CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J 19 3304 3313
54. DaviesSP
ReddyH
CaivanoM
CohenP
2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 95 105
55. SoltoffSP
2001 Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J Biol Chem 276 37986 37992
56. MatznerN
ZemtsovaIM
NguyenTX
DuszenkoM
ShumilinaE
2008 Ion channels modulating mouse dendritic cell functions. J Immunol 181 6803 6809
57. ZengH
LozinskayaIM
LinZ
WilletteRN
BrooksDP
2006 Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator. J Pharmacol Exp Ther 319 957 962
58. SavinaA
JancicC
HuguesS
GuermonprezP
VargasP
2006 NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126 205 218
59. LutzMB
RovereP
KleijmeerMJ
RescignoM
AssmannCU
1997 Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 159 3707 3716
60. GeijtenbeekTB
KwonDS
TorensmaR
van VlietSJ
van DuijnhovenGC
2000 DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 587 597
61. AdamsWC
BondE
HavengaMJ
HoltermanL
GoudsmitJ
2009 Adenovirus Serotype 5 Infects Human Dendritic Cells via a CAR-Independent Receptor Pathway Mediated by Lactoferrin and DC-SIGN. J Gen Virol 90 (Pt 7) 1600 1610
62. de WitteL
AbtM
Schneider-SchauliesS
van KooykY
GeijtenbeekTB
2006 Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 80 3477 3486
63. LozachPY
Lortat-JacobH
de Lacroix de LavaletteA
StaropoliI
FoungS
2003 DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278 20358 20366
64. HalaryF
AmaraA
Lortat-JacobH
MesserleM
DelaunayT
2002 Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17 653 664
65. RobinsonMJ
SanchoD
SlackEC
LeibundGut-LandmannS
Reis e SousaC
2006 Myeloid C-type lectins in innate immunity. Nat Immunol 7 1258 1265
66. von DelwigA
HilkensCM
AltmannDM
HolmdahlR
IsaacsJD
2006 Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Res Ther 8 R93
67. WolffeEJ
VijayaS
MossB
1995 A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211 53 63
68. SchmelzM
SodeikB
EricssonM
WolffeEJ
ShidaH
1994 Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68 130 147
69. TurvilleSG
SantosJJ
FrankI
CameronPU
WilkinsonJ
2004 Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 2170 2179
70. CarterGC
RodgerG
MurphyBJ
LawM
KraussO
2003 Vaccinia virus cores are transported on microtubules. J Gen Virol 84 2443 2458
71. EarlPL
MossB
1991 Generation of recombinant vaccinia viruses. Supplement 15 ed 16.17.6 8
72. VanderplasschenA
SmithGL
1999 Using confocal microscopy to study virus binding and entry into cells. Methods Enzymol 307 591 607
73. OdellLR
ChauN
MarianaA
GrahamME
RobinsonPJ
2009 Azido and diazarinyl analogues of bis-tyrphostin as asymmetrical inhibitors of dynamin GTPase. ChemMedChem 4 1182 1188
74. MossmanSP
BexF
BerglundP
ArthosJ
O'NeilSP
1996 Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol 70 1953 1960
75. HarmanAN
WilkinsonJ
ByeCR
BosnjakL
SternJL
2006 HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177 7103 7113
76. LewinSR
VesanenM
KostrikisL
HurleyA
DuranM
1999 Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol 73 6099 6103
77. RasbandWS
1997–2010 ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA. http://rsb.info.nih.gov/ij/
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 4
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- The Effect of Vaccination on the Evolution and Population Dynamics of Avian Paramyxovirus-1
- Reconstitution of SARS-Coronavirus mRNA Cap Methylation
- Deficiencies in Jasmonate-Mediated Plant Defense Reveal Quantitative Variation in Pathogenesis
- A Timescale for Evolution, Population Expansion, and Spatial Spread of an Emerging Clone of Methicillin-Resistant